|
Market Closed -
Euronext Paris
09:25:00 21/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 7.760 EUR | +2.11% |
|
+1.57% | +24.16% |
| Market Cap | 4.37Cr 5.1Cr 4.09Cr 3.74Cr 7.03Cr 488.58Cr 7.12Cr 48Cr 19Cr 245.22Cr 19Cr 19Cr 811.57Cr | P/E 2026 * |
-19.9x | P/E 2027 * | 194x |
|---|---|---|---|---|---|
| Enterprise Value | 4.22Cr 4.93Cr 3.95Cr 3.61Cr 6.78Cr 471.81Cr 6.87Cr 47Cr 18Cr 236.81Cr 19Cr 18Cr 783.72Cr | EV / Sales 2026 * |
3.84x | EV / Sales 2027 * | 2.68x |
| Free-Float |
14.95% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.11% | ||
| 1 week | +1.57% | ||
| Current month | +0.78% | ||
| 1 month | -6.95% | ||
| 3 months | -13.78% | ||
| 6 months | +15.82% | ||
| Current year | +24.16% |
| 1 week | 7.54 | 7.76 | |
| 1 month | 7.02 | 8.4 | |
| Current year | 6 | 9.1 | |
| 1 year | 5.9 | 9.1 | |
| 3 years | 2.25 | 9.1 | |
| 5 years | 1.9 | 9.1 | |
| 10 years | 1.9 | 9.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 29/12/2008 | |
Renaut Fritsch
DFI | Director of Finance/CFO | - | 01/06/2022 |
Thibaut Bastien
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.11% | +1.57% | +22.20% | +218.03% | 5Cr | ||
| +0.88% | +3.84% | +77.96% | +129.75% | 1,10900Cr | ||
| +1.07% | +3.11% | +51.11% | +56.67% | 64TCr | ||
| +1.20% | +5.64% | +26.68% | +76.48% | 46TCr | ||
| +1.02% | +3.67% | +43.14% | +47.27% | 37TCr | ||
| +0.85% | +2.97% | +24.48% | +42.54% | 30TCr | ||
| +1.26% | +4.54% | +2.20% | +14.84% | 26TCr | ||
| +1.88% | +5.14% | +48.20% | +67.80% | 23TCr | ||
| +1.59% | +0.87% | -12.95% | -51.91% | 20TCr | ||
| +1.87% | +5.78% | +23.07% | +92.57% | 18TCr | ||
| Average | +1.06% | +2.65% | +30.61% | +69.40% | 37.61TCr | |
| Weighted average by Cap. | +0.51% | +3.26% | +44.79% | +72.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.1Cr 1.28Cr 1.03Cr 94.17L 1.77Cr 122.96Cr 1.79Cr 12Cr 4.74Cr 62Cr 4.82Cr 4.72Cr 204.24Cr | 1.6Cr 1.87Cr 1.5Cr 1.37Cr 2.57Cr 178.85Cr 2.6Cr 18Cr 6.89Cr 90Cr 7.01Cr 6.86Cr 297.08Cr |
| Net income | -22.5L -26.28L -21.04L -19.26L -36.16L -25Cr -36.63L -2.49Cr -96.94L -13Cr -98.64L -96.5L -42Cr | 2L 3L 2L 2L 4L 2.79Cr 4L 27.64L 10.77L 1.4Cr 10.96L 10.72L 4.64Cr |
| Net Debt | -15L -17.52L -14.03L -12.84L -24.11L -17Cr -24.42L -1.66Cr -64.62L -8.42Cr -65.76L -64.33L -28Cr | -9L -10.51L -8L -8L -14.47L -10Cr -14.65L -99.49L -38.77L -5.05Cr -39.46L -38.6L -17Cr |
Employees
45
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | €7.760 | +2.11% | 447 |
| 20/26/20 | €7.600 | +0.26% | 120 |
| 19/26/19 | €7.580 | +0.53% | 5 |
| 18/26/18 | €7.540 | 0.00% | 922 |
| 17/26/17 | €7.540 | -1.31% | 1,318 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
7.760EUR
Average target price
8.200EUR
Spread / Average Target
+5.67%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALSMA Stock
Select your edition
All financial news and data tailored to specific country editions
















